10-Q · 2026-10-29
Pediatrix Medical Group, Inc. reports its Q3 results, indicating growth in patient services and revenue streams, impacting the services-hospitals sector.
| Name | Pediatrix Medical Group, Inc. |
|---|---|
| CIK | 0000893949 |
| Tickers | MD |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 8060 Services-Hospitals |
| EIN | 263667538 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | FL FL |
| Phone | 9543840175 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Pediatrix Medical Group, Inc. reports its Q3 results, indicating growth in patient services and revenue streams, impacting the services-hospitals sector.
Pediatrix Medical Group reports Q3 2026 financial results, revealing key operational insights and industry implications.
1475 filing rows loaded from submissions recent; extra archives: CIK0000893949-submissions-001.json (473 filings, 1996-05-10 to 2009-05-31).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-29 | 10-Q | 10-Q | 0001193125-26-436952 | 001-12111 | 261497394 | 34 | 7155119 | 1 | 1 | |
| 2026-10-29 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-436932 | 001-12111 | 261497354 | 34 | 1684851 | 1 | 1 |
| 2026-09-14 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-061930 | 001-12111 | 261378626 | 33 | 9200 | |||
| 2026-09-14 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-061929 | 001-12111 | 261378625 | 33 | 7906 | |||
| 2026-09-14 | 4 | 4 | 0001193125-26-390731 | 4657 | ||||||
| 2026-09-10 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-061367 | 001-12111 | 261371436 | 33 | 4718 | |||
| 2026-09-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100121-26-001021 | 005-46595 | 261358076 | 34 | 8017 | |||
| 2026-09-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001530 | 005-46595 | 261358013 | 34 | 8071 | |||
| 2026-09-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002720 | 005-46595 | 261357781 | 34 | 7843 | |||
| 2026-08-18 | 4 | 4 | 0001193125-26-355656 | 5206 | ||||||
| 2026-08-14 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-057186 | 001-12111 | 261283997 | 33 | 5279 | |||
| 2026-08-14 | 4 | 4 | 0001193125-26-352534 | 5793 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352532 | 4871 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352531 | 4940 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352527 | 4958 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352528 | 4876 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352526 | 4931 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352524 | 4930 | ||||||
| 2026-08-14 | 4 | 4 | 0001193125-26-352522 | 4975 | ||||||
| 2026-08-04 | 10-Q | 10-Q | 0001193125-26-331513 | 001-12111 | 261235387 | 34 | 6767322 | 1 | 1 | |
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-331488 | 001-12111 | 261235362 | 34 | 1638210 | 1 | 1 |
| 2026-07-24 | 8-K | 8-K | 5.02,7.01 | 0001193125-26-316225 | 001-12111 | 261202191 | 34 | 929125 | 1 | 1 |
| 2026-07-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-304033 | 001-12111 | 261175846 | 34 | 1212608 | 1 | 1 |
| 2026-07-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000354204-26-000805 | 005-46595 | 261173606 | 34 | 8779 | |||
| 2026-06-24 | 4 | 4 | 0001193125-26-281304 | 7864 | ||||||
| 2026-06-24 | 3 | 3 | 0001193125-26-281238 | 20218 | ||||||
| 2026-06-10 | 4 | 4 | 0001193125-26-266014 | 6819 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-255710 | 6720 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-255705 | 10518 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-255704 | 6730 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-255703 | 5827 | ||||||
| 2026-05-21 | S-8 | S-8 | 0001193125-26-234596 | 333-296121 | 261009110 | 33 | 330403 | 1 | 1 | |
| 2026-05-14 | 4 | 4 | 0001193125-26-224280 | 6173 | ||||||
| 2026-05-14 | 4 | 4 | 0001193125-26-224279 | 6610 | ||||||
| 2026-05-13 | 144 | xsl144X01/primary_doc.xml | 0000905148-26-002256 | 001-12111 | 26975385 | 33 | 6969 | |||
| 2026-05-13 | 4 | 4 | 0001193125-26-221884 | 5973 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217256 | 4909 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217253 | 4936 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217242 | 21234 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217235 | 21191 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217234 | 21213 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217227 | 22156 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217222 | 22060 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217219 | 4854 | ||||||
| 2026-05-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-212117 | 001-12111 | 26954049 | 34 | 1036919 | 1 | 1 |
| 2026-05-05 | 10-Q | 10-Q | 0001193125-26-204993 | 001-12111 | 26940352 | 34 | 6042844 | 1 | 1 | |
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-204982 | 001-12111 | 26940307 | 34 | 1475153 | 1 | 1 |
| 2026-04-17 | DEFA14A | DEFA14A | 0001193125-26-161594 | 001-12111 | 26871852 | 34 | 137202 | |||
| 2026-03-27 | ARS | ARS | 0001193125-26-127316 | 001-12111 | 26800989 | 34 | 1290374 | |||
| 2026-03-27 | DEFA14A | DEFA14A | 0001193125-26-127310 | 001-12111 | 26800974 | 34 | 1921289 | |||
| 2026-03-27 | DEF 14A | DEF 14A | 0001193125-26-127299 | 001-12111 | 26800965 | 34 | 27514435 | 1 | 1 | |
| 2026-03-03 | 4 | 4 | 0001193125-26-088621 | 7307 | ||||||
| 2026-03-03 | 4 | 4 | 0001193125-26-088620 | 4697 | ||||||
| 2026-02-19 | 10-K | 10-K | 0001193125-26-058074 | 001-12111 | 26651443 | 34 | 13915540 | 1 | 1 | |
| 2026-02-19 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-058063 | 001-12111 | 26651431 | 34 | 1701013 | 1 | 1 |
| 2025-12-17 | 4 | 4 | 0001193125-25-322897 | 21617 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001967940-25-000094 | 001-12111 | 251572126 | 33 | 5012 | |||
| 2025-11-19 | 4 | 4 | 0001193125-25-288277 | 21361 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0000905148-25-004105 | 001-12111 | 251492360 | 33 | 5367 | |||
| 2025-11-10 | 4 | 4 | 0001193125-25-274502 | 21409 | ||||||
| 2025-11-06 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-050236 | 001-12111 | 251458953 | 33 | 4962 | |||
| 2025-11-03 | 10-Q | 10-Q | 0001193125-25-261640 | 001-12111 | 251442068 | 34 | 6982126 | 1 | 1 | |
| 2025-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-261626 | 001-12111 | 251442053 | 34 | 1692708 | 1 | 1 |
| 2025-08-21 | 4 | 4 | 0000950170-25-110715 | 7270 | ||||||
| 2025-08-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-109777 | 001-12111 | 251228470 | 34 | 1191145 | 1 | 1 |
| 2025-08-05 | 4 | 4 | 0000950170-25-103206 | 7731 | ||||||
| 2025-08-05 | 3 | 3 | 0000950170-25-103197 | 20977 | ||||||
| 2025-08-05 | 4 | 4 | 0000950170-25-103196 | 4721 | ||||||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-102382 | 001-12111 | 251182729 | 34 | 6814338 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-102375 | 001-12111 | 251182708 | 34 | 1665863 | 1 | 1 |
| 2025-07-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-003090 | 005-46595 | 251132266 | 34 | 11105 | |||
| 2025-07-01 | 3 | 3 | 0000950170-25-092308 | 18895 | ||||||
| 2025-07-01 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-25-092261 | 001-12111 | 251096836 | 34 | 1189580 | 1 | 1 |
| 2025-06-12 | 4 | 4 | 0000950170-25-085534 | 5838 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-081079 | 6571 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-081078 | 5068 | ||||||
| 2025-06-03 | 4 | 4 | 0000950170-25-081076 | 7562 | ||||||
| 2025-06-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001532155-25-000121 | 005-46595 | 251019783 | 34 | 7676 | |||
| 2025-05-27 | 4 | 4 | 0000950170-25-077830 | 5602 | ||||||
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001532155-25-000099 | 005-46595 | 25947016 | 34 | 7653 | |||
| 2025-05-12 | 4 | 4 | 0000950170-25-069435 | 4776 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069434 | 4804 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069433 | 4715 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069432 | 4777 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069431 | 5742 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069430 | 4821 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069429 | 4786 | ||||||
| 2025-05-12 | 4 | 4 | 0000950170-25-069428 | 4721 | ||||||
| 2025-05-08 | 8-K | 8-K | 5.07 | 0000950170-25-067076 | 001-12111 | 25926761 | 34 | 1014914 | 1 | 1 |
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-063951 | 001-12111 | 25915170 | 34 | 5574451 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063946 | 001-12111 | 25915157 | 34 | 1480306 | 1 | 1 |
| 2025-04-18 | 8-K | 8-K | 1.01 | 0000950170-25-055880 | 001-12111 | 25850654 | 34 | 933601 | 1 | 1 |
| 2025-03-28 | ARS | ARS | 0000950170-25-046330 | 001-12111 | 25781432 | 34 | 10839014 | |||
| 2025-03-28 | DEFA14A | DEFA14A | 0000950170-25-046328 | 001-12111 | 25781430 | 34 | 1141093 | |||
| 2025-03-28 | DEF 14A | DEF 14A | 0000950170-25-046327 | 001-12111 | 25781427 | 34 | 32877733 | 1 | 1 | |
| 2025-03-07 | 4 | 4 | 0000950170-25-035657 | 5887 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032358 | 5695 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032354 | 4704 | ||||||
| 2025-02-26 | 4 | 4 | 0000950170-25-027891 | 5612 | ||||||
| 2025-02-21 | 144 | xsl144X01/primary_doc.xml | 0001965353-25-000030 | 001-12111 | 25652790 | 33 | 4370 | |||
| 2025-02-20 | 10-K | 10-K | 0000950170-25-023730 | 001-12111 | 25643220 | 34 | 14000035 | 1 | 1 | |
| 2025-02-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-023723 | 001-12111 | 25643204 | 34 | 1676673 | 1 | 1 |
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-012913 | 005-46595 | 25620006 | 34 | 10479 | |||
| 2025-01-14 | 4 | 4 | 0000950170-25-005487 | 5824 | ||||||
| 2025-01-14 | 8-K | 8-K | 5.02 | 0001193125-25-006190 | 001-12111 | 25529703 | 34 | 189275 | 1 | 1 |
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-004937 | 001-12111 | 25524716 | 34 | 194141 | 1 | 1 |
| 2024-12-05 | 8-K | 8-K | 5.02 | 0000950170-24-133723 | 001-12111 | 241529488 | 34 | 931604 | 1 | 1 |
| 2024-12-03 | 4 | 4 | 0000950170-24-132838 | 5051 | ||||||
| 2024-11-14 | 4 | 4 | 0000950170-24-127164 | 5067 | ||||||
| 2024-11-13 | SC 13G | SC 13G | 0001104659-24-117751 | 005-46595 | 241454867 | 34 | 80656 | |||
| 2024-11-13 | 144 | xsl144X01/primary_doc.xml | 0001967940-24-000086 | 001-12111 | 241453831 | 33 | 4453 | |||
| 2024-11-12 | 4 | 4 | 0000950170-24-125616 | 6094 | ||||||
| 2024-11-08 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000321 | 001-12111 | 241440380 | 33 | 4943 | |||
| 2024-11-04 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000317 | 001-12111 | 241423390 | 33 | 6782 | |||
| 2024-11-01 | 10-Q | 10-Q | 0000950170-24-119796 | 001-12111 | 241417006 | 34 | 6501424 | 1 | 1 | |
| 2024-11-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-119795 | 001-12111 | 241416987 | 34 | 1580137 | 1 | 1 |
| 2024-10-31 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-24-004672 | 005-46595 | 241413735 | 34 | 19467 | |||
| 2024-10-04 | 3 | 3 | 0000950170-24-112963 | 12288 | ||||||
| 2024-09-03 | 4 | 4 | 0000950170-24-102887 | 5092 | ||||||
| 2024-08-30 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000282 | 001-12111 | 241270032 | 33 | 5505 | |||
| 2024-08-29 | 4 | 4 | 0000950170-24-101930 | 5129 | ||||||
| 2024-08-27 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000275 | 001-12111 | 241248964 | 33 | 4465 | |||
| 2024-08-13 | 4 | 4 | 0000950170-24-096399 | 7073 | ||||||
| 2024-08-09 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000253 | 001-12111 | 241193371 | 33 | 8907 | |||
| 2024-08-09 | 144 | xsl144X01/primary_doc.xml | 0001965353-24-000251 | 001-12111 | 241193216 | 33 | 5542 | |||
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091193 | 001-12111 | 241177014 | 34 | 6585553 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,5.02,9.01 | 0000950170-24-091185 | 001-12111 | 241176989 | 34 | 1602509 | 1 | 1 |
| 2024-06-17 | 8-K | 8-K | 5.02 | 0000950170-24-074283 | 001-12111 | 241048683 | 34 | 928713 | 1 | 1 |
| 2024-06-10 | SC 13G/A | PEDIATRIX MEDICAL GROUP, INC. - 05/31/2024 | 0001102578-24-000082 | 005-46595 | 241032100 | 34 | 10715 | |||
| 2024-06-04 | 4 | 4 | 0000950170-24-068809 | 5046 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068806 | 9010 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068805 | 5082 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068804 | 6574 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068803 | 6033 | ||||||
| 2024-05-30 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-066242 | 001-12111 | 241000663 | 34 | 2688636 | 1 | 1 |
| 2024-05-13 | 4 | 4 | 0000950170-24-058793 | 4796 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058791 | 4786 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058792 | 4727 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058788 | 4817 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058787 | 4787 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058784 | 4725 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058786 | 4831 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058783 | 4750 | ||||||
| 2024-05-09 | 8-K | 8-K | 5.07 | 0000950170-24-057093 | 001-12111 | 24931222 | 34 | 994856 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-053922 | 001-12111 | 24919552 | 34 | 5260795 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-053917 | 001-12111 | 24919511 | 34 | 1410614 | 1 | 1 |
| 2024-04-25 | 8-K | 8-K | 1.01 | 0000950170-24-048387 | 001-12111 | 24876883 | 34 | 932077 | 1 | 1 |
| 2024-03-28 | ARS | ARS | 0001193125-24-079580 | 001-12111 | 24793413 | 34 | 750258 | |||
| 2024-03-28 | DEFA14A | DEFA14A | 0001193125-24-079576 | 001-12111 | 24793405 | 34 | 394677 | |||
| 2024-03-28 | DEF 14A | DEF 14A | 0001193125-24-079571 | 001-12111 | 24793396 | 34 | 8242088 | 1 | 1 | |
| 2024-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-24-004844 | 5842 | ||||||
| 2024-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-004393 | 5892 | ||||||
| 2024-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-004389 | 4926 | ||||||
| 2024-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-004394 | 4928 | ||||||
| 2024-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-004387 | 5918 | ||||||
| 2024-03-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-004388 | 4965 | ||||||
| 2024-02-20 | 10-K | 10-K | 0000950170-24-016794 | 001-12111 | 24650662 | 34 | 12662002 | 1 | 1 | |
| 2024-02-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-016790 | 001-12111 | 24650644 | 34 | 1580785 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SEC SCHEDULE 13G | 0001532155-24-000079 | 005-46595 | 24636595 | 34 | 18387 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021688 | 005-46595 | 24629201 | 34 | 13231 | |||
| 2024-02-12 | SC 13G/A | PEDIATRIX MEDICAL GROUP, INC. - 12/31/2023 | 0001102578-24-000046 | 005-46595 | 24622396 | 34 | 10708 | |||
| 2024-02-09 | SC 13G | SEC SCHEDULE 13G | 0000354204-24-003013 | 005-46595 | 24612240 | 34 | 19624 | |||
| 2024-01-22 | SC 13G/A | us58502b1061_012224.txt | 0001086364-24-000809 | 005-46595 | 24548091 | 34 | 13674 | |||
| 2023-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-058804 | 6604 | ||||||
| 2023-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-058799 | 4653 | ||||||
| 2023-12-14 | 144 | xsl144X01/primary_doc.xml | 0001965353-23-000231 | 001-12111 | 231487248 | 33 | 4261 | |||
| 2023-11-02 | 10-Q | 10-Q | 0000950170-23-057738 | 001-12111 | 231369989 | 34 | 6947322 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-057732 | 001-12111 | 231369949 | 34 | 1678269 | 1 | 1 |
| 2023-08-16 | UPLOAD | filename1.pdf | 0000000000-23-008946 | 39833 | ||||||
| 2023-08-08 | CORRESP | filename1.htm | 0000950170-23-039949 | 36706 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0000950170-23-037565 | 001-12111 | 231137993 | 34 | 7502047 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-037559 | 001-12111 | 231137961 | 34 | 1763064 | 1 | 1 |
| 2023-07-27 | UPLOAD | filename1.pdf | 0000000000-23-008061 | 43129 | ||||||
| 2023-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-037952 | 5225 | ||||||
| 2023-06-14 | 144 | xsl144X01/primary_doc.xml | 0001965353-23-000055 | 001-12111 | 231014074 | 33 | 4262 | |||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035486 | 5729 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033878 | 5780 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033877 | 4819 | ||||||
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-032592 | 5189 | ||||||
| 2023-05-24 | 144 | xsl144X01/primary_doc.xml | 0001967940-23-000008 | 001-12111 | 23953592 | 33 | 4357 | |||
| 2023-05-22 | 4 | FORM 4 SUBMISSION | 0001209191-23-031503 | 7255 | ||||||
| 2023-05-19 | 144 | xsl144X01/primary_doc.xml | 0001965407-23-000002 | 001-12111 | 23941905 | 33 | 4786 | |||
| 2023-05-18 | 144 | xsl144X01/primary_doc.xml | 0001965353-23-000031 | 001-12111 | 23936369 | 33 | 5964 | |||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029520 | 4955 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029515 | 4851 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029513 | 4906 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029516 | 4920 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029514 | 4849 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029512 | 5218 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029511 | 4938 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029430 | 5728 | ||||||
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-029419 | 4910 | ||||||
| 2023-05-15 | 3 | FORM 3 SUBMISSION | 0001209191-23-029403 | 5787 | ||||||
| 2023-05-12 | 144 | xsl144X01/primary_doc.xml | 0001969223-23-000097 | 001-12111 | 23915695 | 33 | 12838 | |||
| 2023-05-11 | 8-K | 8-K | 5.07 | 0000950170-23-021326 | 001-12111 | 23911680 | 34 | 1056638 | 1 | 1 |
| 2023-05-10 | 144 | xsl144X01/primary_doc.xml | 0001969223-23-000087 | 001-12111 | 23907881 | 33 | 9327 | |||
| 2023-05-10 | SC 13G/A | Pediatrix.htm | 0001532155-23-000134 | 005-46595 | 23904965 | 34 | 18239 | |||
| 2023-05-04 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-23-017882 | 001-12111 | 23888983 | 34 | 1212775 | 1 | 1 |
| 2023-05-02 | 10-Q | 10-Q | 0000950170-23-016430 | 001-12111 | 23876580 | 34 | 7125042 | 1 | 1 | |
| 2023-05-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-016427 | 001-12111 | 23876564 | 34 | 1575464 | 1 | 1 |
| 2023-03-31 | ARS | ARS | 0001193125-23-086712 | 001-12111 | 23783179 | 34 | 1379341 | |||
| 2023-03-31 | DEFA14A | DEFA14A | 0001193125-23-086708 | 001-12111 | 23783171 | 34 | 1033837 | |||
| 2023-03-31 | DEF 14A | DEF 14A | 0001193125-23-086703 | 001-12111 | 23783163 | 34 | 12798129 | 1 | 1 | |
| 2023-03-08 | 8-K | 8-K | 5.02 | 0000950170-23-006748 | 001-12111 | 23717056 | 34 | 165906 | 1 | 1 |
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015674 | 7153 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015677 | 6829 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015669 | 6836 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015672 | 7189 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015668 | 8143 | ||||||
| 2023-02-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-011724 | 6750 | ||||||
| 2023-02-22 | 3 | FORM 3 SUBMISSION | 0001209191-23-011720 | 6762 | ||||||
| 2023-02-17 | 10-K | 10-K | 0000950170-23-003127 | 001-12111 | 23640256 | 34 | 15313187 | 1 | 1 | |
| 2023-02-17 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-003125 | 001-12111 | 23640247 | 34 | 1027573 | 1 | 1 |
| 2023-02-14 | SC 13G/A | PEDIATRIX MEDICAL GROUP, INC.- 12/31/2022 | 0001102578-23-000035 | 005-46595 | 23622767 | 34 | 10602 | |||
| 2023-02-14 | SC 13G/A | SEC SCHEDULE 13G | 0001532155-23-000108 | 005-46595 | 23621210 | 34 | 18279 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001966 | 005-46595 | 23604795 | 34 | 8278 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-016701 | 005-46595 | 23604018 | 34 | 13124 | |||
| 2023-01-23 | SC 13G/A | us58502b1061_012323.txt | 0001306550-23-002409 | 005-46595 | 23544444 | 34 | 13394 | |||
| 2023-01-20 | SC 13D/A | AMENDMENT NO. 6 TO THE SCHEDULE 13D | 0000921895-23-000157 | 005-46595 | 23541983 | 34 | 527822 | |||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-001044 | 4924 | ||||||
| 2022-12-16 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-22-026632 | 001-12111 | 221466436 | 34 | 436751 | 1 | 1 |
| 2022-12-02 | SC 13D/A | AMENDMENT NO. 5 TO THE SCHEDULE 13D | 0000921895-22-003156 | 005-46595 | 221443101 | 34 | 405394 | |||
| 2022-11-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-058674 | 7909 | ||||||
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-056208 | 7898 | ||||||
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021526 | 001-12111 | 221356112 | 34 | 6895348 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-021516 | 001-12111 | 221356068 | 34 | 1035447 | 1 | 1 |
| 2022-09-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-051470 | 4828 | ||||||
| 2022-09-23 | 8-K | FORM 8-K | 5.02 | 0001193125-22-250187 | 001-12111 | 221262678 | 34 | 139813 | 1 | 1 |
| 2022-08-04 | 10-Q | 10-Q | 0000950170-22-014473 | 001-12111 | 221134676 | 34 | 6792208 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-014467 | 001-12111 | 221134648 | 34 | 1018928 | 1 | 1 |
| 2022-06-21 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-011839 | 001-12111 | 221026020 | 34 | 239106 | 1 | 1 |
| 2022-05-17 | 8-K | 8-K | 5.02,5.07 | 0000950170-22-010201 | 001-12111 | 22935553 | 34 | 273956 | 1 | 1 |
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028911 | 4695 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028908 | 4752 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028907 | 7472 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028903 | 4696 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028902 | 4766 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028901 | 4804 | ||||||
| 2022-05-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-028898 | 4697 | ||||||
| 2022-05-13 | 3 | FORM 3 SUBMISSION | 0001209191-22-028836 | 5704 | ||||||
| 2022-04-28 | 10-Q | 10-Q | 0000950170-22-006427 | 001-12111 | 22862117 | 34 | 5411421 | 1 | 1 | |
| 2022-04-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-006426 | 001-12111 | 22862098 | 34 | 576832 | 1 | 1 |
| 2022-04-01 | DEFA14A | DEFA14A | 0001193125-22-093828 | 001-12111 | 22799240 | 34 | 654671 | |||
| 2022-04-01 | DEF 14A | DEF 14A | 0001193125-22-093819 | 001-12111 | 22799164 | 34 | 9642281 | |||
| 2022-03-21 | PRE 14A | PRE 14A | 0001193125-22-080606 | 001-12111 | 22756063 | 34 | 4797833 | |||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015591 | 5217 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015594 | 9548 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015593 | 10206 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015586 | 9511 | ||||||
| 2022-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-015588 | 9543 | ||||||
| 2022-02-25 | 8-K | 8-K | 5.02 | 0000950170-22-002114 | 001-12111 | 22681569 | 34 | 157155 | 1 | 1 |
| 2022-02-17 | 10-K | 10-K | 0000950170-22-001387 | 001-12111 | 22645608 | 34 | 14331698 | 1 | 1 | |
| 2022-02-17 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-001386 | 001-12111 | 22645587 | 34 | 757035 | 1 | 1 |
| 2022-02-14 | SC 13G/A | MEDNAX.htm | 0001532155-22-000037 | 005-46595 | 22630246 | 34 | 18137 | |||
| 2022-02-14 | SC 13G/A | arrowmark-md123121a2.htm | 0001172661-22-000692 | 005-46595 | 22629982 | 34 | 54189 | |||
| 2022-02-14 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0000950170-22-001148 | 001-12111 | 22625074 | 34 | 3689234 | 1 | 1 |
| 2022-02-11 | SC 13G/A | MEDNAX, INC. - 12/31/2021 | 0001102578-22-000037 | 005-46595 | 22615562 | 34 | 10446 | |||
| 2022-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-018074 | 005-46595 | 22610401 | 34 | 12954 | |||
| 2022-02-09 | SC 13G | filing.txt | 0000315066-22-001106 | 005-46595 | 22604416 | 34 | 8309 | |||
| 2022-01-27 | SC 13G/A | us58502b1061_012722.txt | 0000834237-22-002317 | 005-46595 | 22562291 | 34 | 13231 | |||
| 2022-01-26 | SC 13G/A | us58502b1061_012522.txt | 0000834237-22-000880 | 005-46595 | 22555261 | 34 | 13231 | |||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002943 | 7300 | ||||||
| 2022-01-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-002411 | 5171 | ||||||
| 2022-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-001141 | 7299 | ||||||
| 2021-12-30 | 4 | FORM 4 SUBMISSION | 0001209191-21-071616 | 5172 | ||||||
| 2021-12-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-071507 | 9432 | ||||||
| 2021-11-23 | 3 | FORM 3 SUBMISSION | 0001209191-21-066515 | 7613 | ||||||
| 2021-11-19 | 8-K | 8-K | 5.02,5.03,8.01,9.01 | 0000950170-21-004821 | 001-12111 | 211429477 | 34 | 394425 | 1 | 1 |
| 2021-11-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-063836 | 5484 | ||||||
| 2021-11-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-063832 | 5236 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-062083 | 5286 | ||||||
| 2021-10-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-062082 | 4608 | ||||||
| 2021-10-28 | 10-Q | 10-Q | 0000950170-21-002406 | 001-12111 | 211355002 | 34 | 6164721 | 1 | 1 | |
| 2021-10-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-002405 | 001-12111 | 211354980 | 34 | 938504 | 1 | 1 |
| 2021-10-06 | 4 | FORM 4 SUBMISSION | 0001209191-21-059844 | 4607 | ||||||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-054746 | 5289 | ||||||
| 2021-08-31 | 4 | FORM 4 SUBMISSION | 0001209191-21-054168 | 10051 | ||||||
| 2021-08-31 | SC 13D/A | AMENDMENT NO. 4 TO THE SCHEDULE 13D | 0001193805-21-001252 | 005-46595 | 211225512 | 34 | 429339 | |||
| 2021-08-27 | 8-K | 8-K | 8.01 | 0000950170-21-001577 | 001-12111 | 211219302 | 34 | 157943 | 1 | 1 |
| 2021-08-11 | 4 | FORM 4 SUBMISSION | 0001209191-21-050907 | 5506 | ||||||
| 2021-08-06 | S-8 | S-8 | 0001193125-21-239274 | 333-258576 | 211153190 | 33 | 61669 | |||
| 2021-08-06 | S-8 | S-8 | 0001193125-21-239266 | 333-258572 | 211153157 | 33 | 62146 | |||
| 2021-08-06 | 10-Q | 10-Q | 0000950170-21-000978 | 001-12111 | 211150521 | 34 | 6108668 | 1 | 1 | |
| 2021-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-238355 | 001-12111 | 211150489 | 34 | 289970 | 1 | 1 |
| 2021-07-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-046555 | 4620 | ||||||
| 2021-07-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-045052 | 5189 | ||||||
| 2021-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-037166 | 4885 | ||||||
| 2021-05-17 | 8-K | 8-K | 1.01 | 0001193125-21-163735 | 001-12111 | 21931155 | 34 | 142886 | 1 | 1 |
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032733 | 7401 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032727 | 7480 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032724 | 7526 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032719 | 4755 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032716 | 4697 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032715 | 7405 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032713 | 4707 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032709 | 4687 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032707 | 4851 | ||||||
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032703 | 4700 | ||||||
| 2021-05-14 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-161991 | 001-12111 | 21924526 | 34 | 181256 | 1 | 1 |
| 2021-05-07 | 10-Q | 10-Q | 0001193125-21-154019 | 001-12111 | 21900184 | 34 | 3599119 | 1 | 1 | |
| 2021-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-154005 | 001-12111 | 21900161 | 34 | 254196 | 1 | 1 |
| 2021-04-02 | 4 | FORM 4 SUBMISSION | 0001209191-21-024762 | 6710 | ||||||
| 2021-03-23 | DEFA14A | DEFA14A | 0001193125-21-091215 | 001-12111 | 21765034 | 34 | 977733 | |||
| 2021-03-23 | DEF 14A | DEF 14A | 0001193125-21-091206 | 001-12111 | 21764999 | 34 | 7690396 | |||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016912 | 9400 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016905 | 7506 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016899 | 7525 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016895 | 4619 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016887 | 9423 | ||||||
| 2021-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-016882 | 7528 | ||||||
| 2021-02-18 | 10-K | 10-K | 0001193125-21-047064 | 001-12111 | 21647633 | 34 | 10733094 | 1 | 1 | |
| 2021-02-18 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-047053 | 001-12111 | 21647626 | 34 | 282507 | 1 | 1 |
| 2021-02-16 | SC 13G | MEDNAX, INC. - 12/31/2020 | 0001102578-21-000040 | 005-46595 | 21637919 | 34 | 10445 | |||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G HOLDINGS REPORT AMENDMENT | 0001172661-21-000635 | 005-46595 | 21635613 | 34 | 54038 | |||
| 2021-02-12 | SC 13G/A | SEC SCHEDULE 13G | 0000354204-21-000167 | 005-46595 | 21626342 | 34 | 19397 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-018611 | 005-46595 | 21611388 | 34 | 13823 | |||
| 2021-02-08 | SC 13G | SEC SCHEDULE 13G | 0001532155-21-000026 | 005-46595 | 21597749 | 34 | 18142 | |||
| 2021-01-26 | SC 13G/A | us58502b1061_012621.txt | 0000834237-21-001403 | 005-46595 | 21553352 | 34 | 13212 | |||
| 2021-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-001146 | 7332 | ||||||
| 2020-12-21 | 8-K | FORM 8-K | 2.01,2.04,7.01,8.01,9.01 | 0001193125-20-323140 | 001-12111 | 201404603 | 34 | 427037 | 1 | 1 |
| 2020-12-11 | 4 | FORM 4 SUBMISSION | 0001209191-20-062948 | 10802 | ||||||
| 2020-12-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-20-133976 | 005-46595 | 201379630 | 34 | 13820 | |||
| 2020-11-24 | 8-K | 8-K | 8.01 | 0001193125-20-302610 | 001-12111 | 201344354 | 34 | 145584 | 1 | 1 |
| 2020-11-06 | 10-Q | 10-Q | 0001193125-20-287356 | 001-12111 | 201292365 | 34 | 5611995 | 1 | 1 | |
| 2020-11-06 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-20-287348 | 001-12111 | 201292349 | 34 | 281377 | 1 | 1 |
| 2020-10-02 | 3 | FORM 3 SUBMISSION | 0001209191-20-053152 | 8774 | ||||||
| 2020-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-053146 | 4769 | ||||||
| 2020-09-29 | 3 | FORM 3 SUBMISSION | 0001209191-20-052408 | 10991 | ||||||
| 2020-09-29 | 8-K | 8-K | 5.02 | 0001193125-20-257929 | 001-12111 | 201209653 | 34 | 150590 | 1 | 1 |
| 2020-09-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-052356 | 8085 | ||||||
| 2020-09-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-050960 | 5223 | ||||||
| 2020-09-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-050955 | 5082 | ||||||
| 2020-09-15 | 8-K | 8-K | 1.01,5.07,9.01 | 0001193125-20-245502 | 001-12111 | 201174533 | 34 | 957065 | 1 | 1 |
| 2020-09-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-20-242587 | 001-12111 | 201167714 | 34 | 182444 | 1 | 1 |
| 2020-08-25 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-20-229109 | 001-12111 | 201129541 | 34 | 176375 | 1 | 1 |
| 2020-07-30 | 10-Q | 10-Q | 0001193125-20-203325 | 001-12111 | 201059128 | 34 | 4724864 | 1 | 1 | |
| 2020-07-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-203317 | 001-12111 | 201059101 | 34 | 286649 | 1 | 1 |
| 2020-07-28 | DEFA14A | DEFA14A | 0001193125-20-201012 | 001-12111 | 201054179 | 34 | 95553 | |||
| 2020-07-28 | DEF 14A | DEF 14A | 0001193125-20-200999 | 001-12111 | 201054068 | 34 | 3102442 | |||
| 2020-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-042535 | 7605 | ||||||
| 2020-07-15 | 3 | FORM 3 SUBMISSION | 0001209191-20-042533 | 6292 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042457 | 7526 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042456 | 7651 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042455 | 12746 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042453 | 7530 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042451 | 4765 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042448 | 4723 | ||||||
| 2020-07-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-042446 | 4705 | ||||||
| 2020-07-14 | 3 | FORM 3 SUBMISSION | 0001209191-20-042445 | 6214 | ||||||
| 2020-07-14 | 3 | FORM 3 SUBMISSION | 0001209191-20-042444 | 6340 | ||||||
| 2020-07-14 | 3 | FORM 3 SUBMISSION | 0001209191-20-042443 | 5716 | ||||||
| 2020-07-14 | 3 | FORM 3 SUBMISSION | 0001209191-20-042442 | 6217 | ||||||
| 2020-07-13 | SC 13D/A | AMENDMENT NO. 3 TO THE SCHEDULE 13D | 0000921895-20-001971 | 005-46595 | 201025858 | 34 | 759509 | |||
| 2020-07-13 | DEFA14A | DEFA14A | 0001193125-20-191604 | 001-12111 | 201024420 | 34 | 354265 | |||
| 2020-07-13 | 8-K | FORM 8-K | 1.01,5.02,7.01,9.01 | 0001193125-20-191602 | 001-12111 | 201024416 | 34 | 587007 | 1 | 1 |
| 2020-07-10 | SC 13G/A | us58502b1061_071020.txt | 0000834237-20-010000 | 005-46595 | 201022171 | 34 | 13371 | |||
| 2020-06-15 | DEFA14A | DEFA14A | 0001193125-20-168100 | 001-12111 | 20961775 | 34 | 21715 | |||
| 2020-06-15 | 8-K | 8-K | 8.01 | 0001193125-20-168098 | 001-12111 | 20961774 | 34 | 149265 | 1 | 1 |
| 2020-06-05 | DEFA14A | DEFA14A | 0001193125-20-161343 | 001-12111 | 20944639 | 34 | 59319 | |||
| 2020-06-05 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-20-161340 | 001-12111 | 20944637 | 34 | 199244 | 1 | 1 |
| 2020-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-034030 | 4847 | ||||||
| 2020-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-034023 | 4921 | ||||||
| 2020-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-034017 | 4693 | ||||||
| 2020-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-034009 | 4674 | ||||||
| 2020-05-15 | SC 13D/A | AMENDMENT NO. 2 TO THE SCHEDULE 13D | 0001193805-20-000593 | 005-46595 | 20880889 | 34 | 633568 | |||
| 2020-05-12 | 8-K | 8-K | 1.01,2.01,9.01 | 0001193125-20-140531 | 001-12111 | 20869693 | 34 | 975523 | 1 | 1 |
| 2020-05-07 | 10-Q | 10-Q | 0001193125-20-136311 | 001-12111 | 20856868 | 34 | 5665295 | 1 | 1 | |
| 2020-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-135547 | 001-12111 | 20854483 | 34 | 247205 | 1 | 1 |
| 2020-05-06 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-20-134447 | 001-12111 | 20851434 | 34 | 213563 | 1 | 1 |
| 2020-04-28 | 10-K/A | FORM 10-K/A | 0001193125-20-123354 | 001-12111 | 20826182 | 34 | 2652158 | 1 | 1 | |
| 2020-04-07 | 8-K | 8-K | 5.02 | 0001193125-20-100475 | 001-12111 | 20779891 | 34 | 143556 | 1 | 1 |
| 2020-03-25 | 8-K | 8-K | 1.01,2.03,7.01,8.01,9.01 | 0001564590-20-012671 | 001-12111 | 20739948 | 34 | 218272 | 1 | 1 |
| 2020-03-09 | 8-K | 8-K | 8.01 | 0001193125-20-067220 | 001-12111 | 20698347 | 34 | 141914 | 1 | 1 |
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015322 | 9084 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015316 | 4694 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015304 | 4692 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-20-015297 | 9099 | ||||||
| 2020-03-02 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | 0000921895-20-000633 | 005-46595 | 20678423 | 34 | 614856 | |||
| 2020-02-20 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-042625 | 001-12111 | 20632503 | 34 | 295164 | 1 | 1 |
| 2020-02-20 | 10-K | 10-K | 0001193125-20-042622 | 001-12111 | 20632501 | 34 | 13549372 | 1 | 1 | |
| 2020-02-19 | 3 | FORM 3 SUBMISSION | 0001209191-20-010748 | 9817 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010338 | 4790 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010334 | 4753 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010333 | 4816 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010332 | 5665 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010331 | 4758 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010330 | 5472 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010328 | 4870 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010327 | 4748 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010326 | 5758 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010324 | 5471 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010322 | 4912 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010321 | 4761 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010320 | 5454 | ||||||
| 2020-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-20-010319 | 4811 | ||||||
| 2020-02-18 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-000740 | 227078 | ||||||
| 2020-02-14 | SC 13G | SCHEDULE 13G HOLDINGS REPORT | 0001172661-20-000893 | 005-46595 | 20621122 | 34 | 54007 | |||
| 2020-02-14 | SC 13G/A | md13gadec19.txt | 0000080255-20-001019 | 005-46595 | 34 | 7005 | ||||
| 2020-02-14 | DFAN14A | dfan14a06297280_02132020.htm | 0000921895-20-000456 | 001-12111 | 20613201 | 34 | 565100 | |||
| 2020-02-13 | SC 13D | SCHEDULE 13D | 0000921895-20-000442 | 005-46595 | 20612231 | 34 | 813408 |
One latest value per concept from companyfacts (536 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 78.12M | 2026-10-27 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 899.92M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| srt | StockRepurchaseProgramAuthorizedAmount1 | StockRepurchaseProgramAuthorizedAmount1 | USD | 250.00M | 2025-08-31 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AcceleratedShareRepurchasesSettlementPaymentOrReceipt | Accelerated Share Repurchases, Settlement (Payment) or Receipt | USD | 200.00M | 2015-03-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 342.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 25.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AccountsReceivableGrossCurrent | Accounts Receivable, before Allowance for Credit Loss, Current | USD | 1.34B | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 231.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AccretionExpense | Accretion Expense | USD | 1.32M | 2013-01-01 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-10-31 | 0001193125-13-420886 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 194.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 132.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 886.88M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 850.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 3.20M | 2016-04-01 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 6.20M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet | Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net | USD | 4.20M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.70M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-05 | 0001193125-26-204993 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 20.00M | 2011-01-01 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-01 | 0001193125-11-290716 |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 1.08B | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 214,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 5.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 91,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | AssetAcquisitionContingentConsiderationLiability | AssetAcquisitionContingentConsiderationLiability | USD | 3.50M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-03 | 0001193125-25-261640 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | Assets | Assets | USD | 2.14B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 684.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroup | Assets Held-for-sale, Not Part of Disposal Group | USD | 46.00M | 2017-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrent | Assets Held-for-sale, Not Part of Disposal Group, Current | USD | 23.50M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther | Assets Held-for-sale, Not Part of Disposal Group, Current, Other | USD | 22.50M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Assets | USD | 691.18M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 98.51M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-28 | 0000950170-21-002406 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 74.51M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 113.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 113.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | BuildingsAndImprovementsGross | Buildings and Improvements, Gross | USD | 8.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | BusinessAcquisitionContingentConsiderationAtFairValue | Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) | USD | 6.10M | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 | |
| us-gaap | BusinessAcquisitionContingentConsiderationPotentialCashPayment | Business Acquisition, Contingent Consideration, Potential Cash Payment (Deprecated 2013-01-31) | USD | 0 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityCashPaid | Business Acquisition, Cost of Acquired Entity, Cash Paid (Deprecated 2013-01-31) | USD | 26.80M | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 | |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityPurchasePrice | Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) | USD | 32.90M | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 | |
| us-gaap | BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned | Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | USD | 2.70M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued | Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares | 69,014 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 |
| us-gaap | BusinessAcquisitionPreexistingRelationshipGainLossRecognized | Business Acquisition, Preexisting Relationship, Gain (Loss) Recognized (Deprecated 2014-01-31) | USD | 0 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389697 | |
| us-gaap | BusinessAcquisitionProFormaEarningsPerShareBasic | Business Acquisition, Pro Forma Earnings Per Share, Basic | USD/shares | 3.57 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | BusinessAcquisitionProFormaEarningsPerShareDiluted | Business Acquisition, Pro Forma Earnings Per Share, Diluted | USD/shares | 3.54 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets | Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets (Deprecated 2013-01-31) | USD | 8.30M | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCapitalLeaseObligationAccrual | Business Acquisition, Purchase Price Allocation, Capital Lease Obligation Accrual (Deprecated 2013-01-31) | USD | 2.00M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationCurrentLiabilities | Business Acquisition, Purchase Price Allocation, Current Liabilities (Deprecated 2013-01-31) | USD | 1.40M | 2012-06-30 | 2012 | Q2 | 10-Q | 2012-07-31 | 0001193125-12-325900 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationGoodwillAmount | Business Acquisition, Purchase Price Allocation, Goodwill Amount (Deprecated 2013-01-31) | USD | 24.60M | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount | Business Acquisition, Goodwill, Expected Tax Deductible Amount | USD | 7.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationOtherLiabilities | Business Acquisition, Purchase Price Allocation, Other Liabilities (Deprecated 2013-01-31) | USD | 12.00M | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | BusinessAcquisitionPurchasePriceAllocationPropertyPlantAndEquipment | Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment (Deprecated 2013-01-31) | USD | 600,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | 329.72M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 3.34B | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | BusinessCombinationConsiderationTransferred1 | Business Combination, Consideration Transferred | USD | 47.00M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | BusinessCombinationConsiderationTransferredLiabilitiesIncurred | Business Combination, Consideration Transferred, Liabilities Incurred | USD | 2.40M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-31 | 0001193125-14-289739 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (Deprecated 2013-01-31) | USD | 37.50M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-02 | 0001193125-13-196162 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 5.30M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | USD | 4.10M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueLow | Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low | USD | 0 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 | |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 3.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 8.50M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized | Business Combination, Liabilities Arising from Contingencies, Amount Recognized | USD | 20.00M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets | USD | 11.80M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389697 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | USD | 300,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities | USD | 14.40M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389697 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other | USD | 400,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent | USD | 23.90M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389697 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles | USD | 400,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other | USD | 14.20M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets | USD | 900,000 | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment | USD | 400,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net | USD | 346.80M | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-30 | 0001193125-14-389697 | |
| us-gaap | BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses | Business Combination, Separately Recognized Transactions, Net Gains and Losses | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 |
| us-gaap | BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1 | Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | USD | 7.70M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 |
| us-gaap | BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage | Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage | pure | 0.75 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 1.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 441,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 253,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | CapitalLeaseObligationsNoncurrent | Capital Lease Obligations, Noncurrent | USD | 188,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDue | Capital Leases, Future Minimum Payments Due | USD | 334,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueCurrent | Capital Leases, Future Minimum Payments Due, Next Twelve Months | USD | 253,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInFiveYears | Capital Leases, Future Minimum Payments Due in Five Years | USD | 63,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInFourYears | Capital Leases, Future Minimum Payments Due in Four Years | USD | 74,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInThreeYears | Capital Leases, Future Minimum Payments Due in Three Years | USD | 74,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CapitalLeasesFutureMinimumPaymentsDueInTwoYears | Capital Leases, Future Minimum Payments Due in Two Years | USD | 114,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 15.00M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 311.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations | Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations | USD | 1.12B | 2020-12-31 | 2021 | Q3 | 10-Q | 2021-10-28 | 0000950170-21-002406 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 13.60M | 2016-06-30 | 2016 | Q2 | 10-Q | 2016-07-28 | 0001193125-16-662264 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -19.26M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001193125-18-152850 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 112.77M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 311.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -63.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Financing Activities, Discontinued Operations | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Investing Activities, Discontinued Operations | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | -1.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | CashSurrenderValueFairValueDisclosure | Cash Surrender Value, Fair Value Disclosure | USD | 10.50M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | CashSurrenderValueOfLifeInsurance | Cash Surrender Value of Life Insurance | USD | 16.30M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001193125-18-315785 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 78.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 78.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 781,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 114.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ContingentConsiderationClassifiedAsEquityFairValueDisclosure | Contingent Consideration Classified as Equity, Fair Value Disclosure | USD | 700,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 596.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 400.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 25.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 171.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 1.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | -2.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | DebtAndCapitalLeaseObligations | Debt and Lease Obligation | USD | 600.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 596.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 1.28B | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.054 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible | Decrease in Unrecognized Tax Benefits is Reasonably Possible | USD | 1.10M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 39.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 45.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 33.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 170.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 61.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | DeferredOtherTaxExpenseBenefit | Deferred Other Tax Expense (Benefit) | USD | 10.80M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 12.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 14.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 24.20M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 216.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 16.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 132.78M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001193125-20-136311 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 187.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 45.96M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 118.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 332.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 23.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 1.69M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 2.57M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts | USD | 6.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | USD | 62.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 29.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 7.30M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals | Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals | USD | 39,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 162.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 8.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 61.98M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001193125-20-136311 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 24,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 128,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 29.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | Depreciation | Depreciation | USD | 14.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 18.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax | Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | USD | 38.54M | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax | Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax | USD | -372.97M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DiscontinuedOperationTaxEffectOfDiscontinuedOperation | Discontinued Operation, Tax Effect of Discontinued Operation | USD | -49.02M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net | USD | 38.12M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current | USD | 23.77M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents | Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | USD | 0 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001193125-20-136311 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationDeferredTaxAssets | Disposal Group, Including Discontinued Operation, Deferred Tax Assets | USD | 13.01M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilitiesCurrent | Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities, Current | USD | 35.66M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization | Disposal Group, Including Discontinued Operation, Depreciation and Amortization | USD | 7.26M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense | Disposal Group, Including Discontinued Operation, General and Administrative Expense | USD | 33.45M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent | Disposal Group, Including Discontinued Operation, Goodwill, Current | USD | 321.56M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent | Disposal Group, Including Discontinued Operation, Intangible Assets, Current | USD | 275.15M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOperatingExpense | Disposal Group, Including Discontinued Operation, Operating Expense | USD | 528.24M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss | Disposal Group, Including Discontinued Operation, Operating Income (Loss) | USD | 20.10M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationOtherExpense | Disposal Group, Including Discontinued Operation, Other Expense | USD | 47,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current | USD | 2.50M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent | Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current | USD | 42.60M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationRevenue | Disposal Group, Including Discontinued Operation, Revenue | USD | 172.70M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | 36.40M | 2020-07-01 | 2020-09-30 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 1.47 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 1.43 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.236 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent | pure | -0.124 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent | pure | 0.379 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-02-12 | 0001193125-14-045903 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | -3.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.018 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 16.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 49.86M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 18.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | EquityMethodInvestmentDividendsOrDistributions | Proceeds from Equity Method Investment, Distribution | USD | 2.63M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.49 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 4.24M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 41.43M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 3.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 1.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 1.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 57.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FinitelivedIntangibleAssetsAcquired1 | Finite-lived Intangible Assets Acquired | USD | 6.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpense | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) | USD | 10.30M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 229.30M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 6.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 811,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 914,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 1.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 2.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsFutureAmortizationExpense | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) | USD | 17.30M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 74.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 13.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | FiniteLivedIntangibleAssetsPeriodIncreaseDecrease | Finite-Lived Intangible Assets, Period Increase (Decrease) | USD | 226.10M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 |
| us-gaap | FiniteLivedIntangibleAssetsUsefulLifeMaximum | Finite-Lived Intangible Assets, Useful Life, Maximum (Deprecated 2012-01-31) | pure | 20 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FiniteLivedIntangibleAssetsUsefulLifeMinimum | Finite-Lived Intangible Assets, Useful Life, Minimum (Deprecated 2012-01-31) | pure | 1 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FiniteLivedIntangibleAssetsWeightedAverageUsefulLife | Finite-Lived Intangible Assets, Weighted-Average Useful Life (Deprecated 2012-01-31) | pure | 2.9 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FixturesAndEquipmentGross | Fixtures and Equipment, Gross | USD | 161.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | FutureAmortizationExpenseYearFive | Future Amortization Expense, Year Five (Deprecated 2012-01-31) | USD | 5.70M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FutureAmortizationExpenseYearFour | Future Amortization Expense, Year Four (Deprecated 2012-01-31) | USD | 8.00M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FutureAmortizationExpenseYearOne | Future Amortization Expense, Year One (Deprecated 2012-01-31) | USD | 12.50M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FutureAmortizationExpenseYearThree | Future Amortization Expense, Year Three (Deprecated 2012-01-31) | USD | 10.10M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | FutureAmortizationExpenseYearTwo | Future Amortization Expense, Year Two (Deprecated 2012-01-31) | USD | 11.70M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | GainLossOnSaleOfInvestments | Gain (Loss) on Sale of Investments | USD | 20.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | GainLossOnSaleOfProperties | Gain (Loss) on Sale of Properties | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 184.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | Goodwill | Goodwill | USD | 1.27B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | GoodwillAcquiredDuringPeriod | Goodwill, Acquired During Period | USD | 7.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | GoodwillImpairedAccumulatedImpairmentLoss | Goodwill, Impaired, Accumulated Impairment Loss | USD | 1.45B | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 150.64M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | GoodwillPeriodIncreaseDecrease | Goodwill, Period Increase (Decrease) | USD | 99.00M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | GoodwillTransfers | Goodwill, Transfers | USD | 7.20M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 |
| us-gaap | HealthCareOrganizationLossContractsExpense | Health Care Organization, Loss Contracts Expense (Deprecated 2016-01-31) | USD | 3.36B | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | HealthCareOrganizationPatientServiceRevenue | Health Care Organization, Patient Service Revenue (Deprecated 2018-01-31) | USD | 756.37M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001193125-18-152850 |
| us-gaap | HealthCareOrganizationRevenue | Health Care Organization, Revenue (Deprecated 2018-01-31) | USD | 901.86M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001193125-18-152850 |
| us-gaap | HealthCareTrustFundAdministrativeExpense | Health Care Trust Fund, Administrative Expense (Deprecated 2016-01-31) | USD | -98.83M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | HeldToMaturitySecuritiesCurrent | Debt Securities, Held-to-maturity, Current | USD | 85.04M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001193125-20-136311 | |
| us-gaap | HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount | Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | USD | 2.12M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount | Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 69.70M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | HeldToMaturitySecuritiesNoncurrent | Debt Securities, Held-to-maturity, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | ImpairmentChargeOnReclassifiedAssets | Impairment Charge on Reclassified Assets | USD | 7.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 7.70M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 27.79M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 20.10M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | 202.69M | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 157.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | 104.36M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-01 | 0001193125-14-177190 |
| us-gaap | IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -99.07M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -1.19 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -1.19 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTax | Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | 3.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 4.70M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 1.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 | |
| us-gaap | IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear | Income Tax Examination, Increase (Decrease) in Liability from Prior Year | USD | 600,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 300,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 200,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 41.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperations | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | USD | 147.26M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability | Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | USD | -70.00M | 2017-10-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 321,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 1.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReceivable | Income Taxes Receivable | USD | 8.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 45.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 3.32M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount | USD | 12.50M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 451,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -662,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -1.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 151,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 9.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | IncomeTaxReconciliationTaxSettlements | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount | USD | 600,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-12 | 0001193125-14-045903 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -74.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 2.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | 5.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | 13.90M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | 53.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInFuturePolicyBenefitReserves | Increase (Decrease) in Future Policy Benefit Reserves | USD | 11.40M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 10.90M | 2010-07-01 | 2010-09-30 | 2011 | Q3 | 10-Q | 2011-11-01 | 0001193125-11-290716 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | -799,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021526 |
| us-gaap | IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | USD | -3.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | -15.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -1.16M | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-04-28 | 0001193125-16-563830 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -11.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -3.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible | Increase in Unrecognized Tax Benefits is Reasonably Possible | USD | 2.20M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 2.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | InsuranceSettlementsReceivable | Insurance Settlements Receivable | USD | 28.50M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 671.74M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-10-27 | 0001193125-16-749764 | |
| us-gaap | InterestExpense | Interest Expense | USD | 20.91M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091193 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 24.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.56M | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 34.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 2.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | InvestmentBuildingAndBuildingImprovements | Investment Building and Building Improvements | USD | 18.50M | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-02 | 0001193125-11-206395 | |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 15.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | InvestmentOwnedAtCost | Investment Owned, at Cost | USD | 20.00M | 2021-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 | |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 419.60M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-04-30 | 0001193125-15-161981 |
| us-gaap | Land | Land | USD | 2.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 42.90M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | LeaseCost | Lease, Cost | USD | 17.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 41.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 1.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 12.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 4.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 7.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 11.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 4.67M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 3.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 200,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | Liabilities | Liabilities | USD | 1.29B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 2.14B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 535.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Liabilities | USD | 59.43M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 | |
| us-gaap | LiabilityForUncertainTaxPositionsCurrent | Liability for Uncertainty in Income Taxes, Current | USD | 7.00M | 2015-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LiabilityForUncertainTaxPositionsNoncurrent | Liability for Uncertainty in Income Taxes, Noncurrent | USD | 3.50M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | LineOfCredit | Long-term Line of Credit | USD | 80.00M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053922 | |
| us-gaap | LineOfCreditFacilityAmountOutstanding | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | USD | 144.00M | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod | Line of Credit Facility, Maximum Amount Outstanding During Period | USD | 650.50M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | LineOfCreditFacilityMaximumBorrowingCapacity | Line of Credit Facility, Maximum Borrowing Capacity | USD | 37.50M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 | |
| us-gaap | LineOfCreditFacilityRemainingBorrowingCapacity | Line of Credit Facility, Remaining Borrowing Capacity | USD | 450.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 611.20M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligations | Long-term Debt and Lease Obligation | USD | 397.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligationsCurrent | Long-term Debt and Lease Obligation, Current | USD | 179.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 20.00M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 750.00M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 20.00M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 130.00M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 130.00M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 30.00M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 1.68B | 2016-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 | |
| us-gaap | LongtermDebtWeightedAverageInterestRate | Long-term Debt, Weighted Average Interest Rate, at Point in Time | pure | 0.009 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-12 | 0001193125-14-045903 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | LongTermLineOfCredit | Long-term Line of Credit, Noncurrent | USD | 368.50M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001193125-20-136311 | |
| us-gaap | MalpracticeLossContingencyAccrualNotRecognized | Malpractice Loss Contingency, Accrual Not Recognized (Deprecated 2012-01-31) | USD | 79.50M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | MalpracticeLossContingencyAccrualNotRecognizedHighEndOfLossRange | Malpractice Loss Contingency, Accrual Not Recognized, High End of Loss Range (Deprecated 2016-01-31) | USD | 8.50M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | MalpracticeLossContingencyAccrualUndiscounted | Malpractice Loss Contingency, Accrual, Undiscounted | USD | 287.90M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | MalpracticeLossContingencyAccrualUndiscountedCurrent | Malpractice Loss Contingency, Accrual, Undiscounted, Current | USD | 33.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | MalpracticeLossContingencyAccrualUndiscountedNoncurrent | Malpractice Loss Contingency, Accrual, Undiscounted, Noncurrent | USD | 235.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | MalpracticeLossContingencyClaimsIncurredInPeriod | Malpractice Loss Contingency, Claims Incurred in Period | USD | 47,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | MalpracticeLossContingencyClaimsIncurredInPriorPeriods | Malpractice Loss Contingency, Claims Incurred in Prior Periods | USD | 42.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | MalpracticeLossContingencyClaimsIncurredNet | Malpractice Loss Contingency, Claims Incurred, Net | USD | 42.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | MalpracticeLossContingencyPeriodIncreaseDecrease | Malpractice Loss Contingency, Period Increase (Decrease) | USD | -643,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001193125-18-152850 |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 | |
| us-gaap | MinorityInterestOwnershipPercentageByParent | Noncontrolling Interest, Ownership Percentage by Parent | pure | 0.75 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-07-30 | 0001193125-15-270938 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 300,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001193125-18-315785 | |
| us-gaap | NetCashProvidedByUsedInDiscontinuedOperations | Net Cash Provided by (Used in) Discontinued Operations | USD | -22,000 | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -165.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -25.71M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -10.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -48.18M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 112.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 114.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 116.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 500,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-11 | 0001193125-16-459842 |
| us-gaap | NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance | Noncontrolling Interest, Increase from Subsidiary Equity Issuance | USD | 232,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -5.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | NumberOfBusinessesAcquired | Number of Businesses Acquired | Acquisition | 15 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 1.30B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 163.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 11.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 12.50M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 37.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 11.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 23.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 20.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 31.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 103.48M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 30.82M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 9.44M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 12.71M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 17.95M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 22.04M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 10.52M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.059 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 355.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 49.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 8.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OtherAssetsMiscellaneousNoncurrent | Other Assets, Miscellaneous, Noncurrent | USD | 37.29M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 57.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 218,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0000950170-23-057738 |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent | USD | 100,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0000950170-23-057738 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -1.35M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 42.90M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-07-31 | 0001193125-14-289739 | |
| us-gaap | OtherIntangibleAssetsNet | Other Intangible Assets, Net | USD | 198.14M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 21.70M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | OtherLiabilitiesFairValueDisclosure | Other Liabilities, Fair Value Disclosure | USD | 36.10M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-01 | 0001193125-12-446668 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 36.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 3.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentForContingentConsiderationLiabilityOperatingActivities | Payment for Contingent Consideration Liability, Operating Activities | USD | 318,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-03 | 0001193125-25-261640 |
| us-gaap | PaymentsForPreviousAcquisition | Payments for Previous Acquisition | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | -526,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 147.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | PaymentsOfLoanCosts | Payments of Loan Costs | USD | 1.76M | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | PaymentsToAcquireBusinessesGross | Payments to Acquire Businesses, Gross | USD | 31.20M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-01 | 0001193125-19-281135 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 19.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PaymentsToAcquireOtherPropertyPlantAndEquipment | Payments to Acquire Other Property, Plant, and Equipment | USD | 12.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 8.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | PriorPeriodReclassificationAdjustment | Prior Period Reclassification Adjustment | USD | 99.80M | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ProceedsAndExcessTaxBenefitFromSharebasedCompensation | Proceeds and Excess Tax Benefit from Share-based Compensation | USD | 1.70M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | 249.70M | 2019-10-10 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 2.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ProceedsFromIssuanceOfSeniorLongTermDebt | Proceeds from Issuance of Senior Long-term Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ProceedsFromMinorityShareholders | Proceeds from Noncontrolling Interests | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -699,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ProceedsFromSaleAndMaturityOfOtherInvestments | Proceeds from Sale and Maturity of Other Investments | USD | 27.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 18.38M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-05 | 0000950170-25-102382 |
| us-gaap | ProceedsFromSaleOfBuildings | Proceeds from Sale of Buildings | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | ProceedsFromSaleOfInvestmentProjects | Proceeds from Sale of Investment Projects | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ProceedsFromSaleOfOtherProductiveAssets | Proceeds from Sale of Other Productive Assets | USD | 6.83M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ProceedsFromSaleOfOtherPropertyPlantAndEquipment | Proceeds from Sale of Other Property, Plant, and Equipment | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-28 | 0000950170-21-002406 |
| us-gaap | ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets | Proceeds from Sales of Business, Affiliate and Productive Assets | USD | 1.08M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | 165.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ProFormaWeightedAverageSharesOutstandingDiluted | Pro Forma Weighted Average Shares Outstanding, Diluted | shares | 93.11M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 171.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 37.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 1.80M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-28 | 0000950170-21-002406 |
| us-gaap | RepaymentsOfLongTermDebtAndCapitalSecurities | Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security | USD | 262,000 | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | RepaymentsOfSeniorDebt | Repayments of Senior Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 20.00M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 | |
| us-gaap | RestrictedStockValueSharesIssuedNetOfTaxWithholdings | Restricted Stock, Value, Shares Issued Net of Tax Withholdings | USD | 1.10M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 19.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 1.47B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | SalesRevenueGoodsNetPercentage | Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) | pure | 1 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 | |
| us-gaap | SelfInsuranceReserveCurrent | Self Insurance Reserve, Current | USD | 179.40M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 15.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 89,842 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value (Deprecated 2012-01-31) | USD | 54.58 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 12.86 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 1.42M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 13.94 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 1.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 10.53 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 987,593 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 9.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 17.29 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.5 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.37 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.32 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.019 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.023 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.021 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-15 | 0001193125-13-062738 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 4.50M | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-04 | 0001193125-17-158793 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 16.91 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | pure | 4.5 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 1.70M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | USD | 44.42 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 887,731 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value | USD/shares | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 500 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | USD | 37.59 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 41,400 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (Deprecated 2012-01-31) | USD | 72.5 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.21 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-18 | 0001193125-21-047064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 16.91 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | pure | 4.8 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 900,000 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) | pure | 1.3 | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 16.91 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 36.25 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 27.72 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 |
| us-gaap | ShareRepurchaseProgramExciseTax | ShareRepurchaseProgramExciseTax | USD | 830,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 50.00M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-04-28 | 0000950170-22-006427 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 | |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 9.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 849.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 849.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 2 | 2013-12-19 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-20 | 0001193125-20-042622 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-03 | 0000950170-22-021526 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-17 | 0000950170-23-003127 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 678,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures | USD | 18.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 4.91M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 22.53M | 2010-01-01 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-24 | 0001193125-11-045579 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 83.04M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | StockRepurchaseProgramAuthorizedAmount1 | Stock Repurchase Program, Authorized Amount | USD | 500.00M | 2018-08-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053922 | |
| us-gaap | StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | shares | 61,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 | |
| us-gaap | StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 | Stock Repurchase Program, Remaining Authorized Repurchase Amount | USD | 21.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 | |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 2.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -2.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 1.02M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 3.67M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-09 | 0001193125-15-039201 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 1.04M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-17 | 0000950170-22-001387 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 5.64M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001193125-19-040891 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 7.70M | 2011-12-31 | 2011 | FY | 10-K | 2012-02-29 | 0001193125-12-089192 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 70,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0000950170-24-016794 |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense | Unrecognized Tax Benefits, Interest on Income Taxes Expense | USD | 4.70M | 2010-07-01 | 2010-09-30 | 2011 | Q3 | 10-Q | 2011-11-01 | 0001193125-11-290716 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 600,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 1.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 395.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | ValuationAllowancesAndReservesAdjustments | SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment | USD | -8.22M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-14 | 0001193125-18-045748 |
| us-gaap | ValuationAllowancesAndReservesBalance | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount | USD | 1.08B | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 | |
| us-gaap | ValuationAllowancesAndReservesChargedToCostAndExpense | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense | USD | 6.18B | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | ValuationAllowancesAndReservesDeductions | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction | USD | -6.22B | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-20 | 0000950170-25-023730 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 4.32M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001193125-26-058074 |
| us-gaap | WeightedAverageBasicSharesOutstandingProForma | Weighted Average Basic Shares Outstanding, Pro Forma | shares | 92.42M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-10 | 0001193125-17-038250 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 81.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 79.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001193125-26-436952 |